Patent details

EP2649086 Title: USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER

Basic Information

Publication number:
EP2649086
PCT Application Number:
US2011064191
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP118467570
PCT Publication Number:
WO2012079000
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER
French Title of Invention:
UTILISATION DE LYMPHOCYTES T MODIFIÉS PAR UN RÉCEPTEUR D'ANTIGÈNES CHIMÉRIQUE POUR TRAITER LE CANCER
German Title of Invention:
VERWENDUNG VON DURCH EINEN CHIMÄREN ANTIGENREZEPTOR MODIFIZIERTEN T-ZELLEN ZUR BEHANDLUNG VON KREBS
SPC Number:
LUC00104

Dates

Filing date:
09/12/2011
Grant date:
19/07/2017
EP Publication Date:
16/10/2013
PCT Publication Date:
14/06/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/07/2017
EP B1 Publication Date:
19/07/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/12/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/07/2017
 
 

Name:
The Trustees of The University of Pennsylvania
Address:
Center for Technology Transfer 3160 Chestnut Street, Suite 200, Philadelphia PA 19104-6283, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
23/08/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MILONE, Michael C.
Address:
United States (US)

2

Name:
KALOS, Michael, D.
Address:
United States (US)

3

Name:
JUNE, Carl, H.
Address:
United States (US)

4

Name:
LEVINE, Bruce, L.
Address:
United States (US)

5

Name:
PORTER, David, L.
Address:
United States (US)

Priority

1

Priority Number:
421470 P
Priority Date:
09/12/2010
Priority Country:
United States (US)

2

Priority Number:
201161502649 P
Priority Date:
29/06/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 35/17;

Publication

European Patent Bulletin

Issue number:
201729
Publication date:
19/07/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/11/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/08/2017 Power Of Attorney 1
25/08/2017 Outgoing Correspondence 1